CIBC World Market
RPRX icon

CIBC World Market’s Royalty Pharma RPRX Stock Holding History

CIBC World Market’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.63M Buy
82,547
+35,121
+74% +$1.83M 0.01% 626
2026
Q1 		$2.28M Buy
+47,426
New +$2.08M ﹤0.01% 728
2025
Q2 		– Sell
-11,023
Closed -$343K – 1464
2025
Q1 		$343K Sell
11,023
-18,256
-62% -$579K ﹤0.01% 1126
2024
Q4 		$747K Buy
29,279
+3,979
+16% +$106K ﹤0.01% 946
2024
Q3 		$716K Buy
25,300
+1,653
+7% +$45.8K ﹤0.01% 896
2024
Q2 		$624K Buy
23,647
+7,895
+50% +$219K ﹤0.01% 907
2024
Q1 		$478K Buy
+15,752
New +$464K ﹤0.01% 997

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC World Market's RPRX Position: Q2 2026 in Review

CIBC World Market increased its Royalty Pharma (RPRX) stake by 74% in Q2 2026, buying an estimated $1.83M and bringing the position to 82,547 shares worth $4.63M. The position accounts for 0.01% of the portfolio, ranked #626.

CIBC World Market first reported a position in RPRX in Q1 2024 and has held it in 7 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • CIBC World Market held 82,547 shares of Royalty Pharma worth $4.63M as of Q2 2026.
  • CIBC World Market bought 35,121 Royalty Pharma shares in Q2 2026, an estimated $1.83M.
  • Royalty Pharma made up 0.01% of CIBC World Market's portfolio in Q2 2026, its #626 holding.
  • CIBC World Market first reported a position in Royalty Pharma in Q1 2024 and has held it in 7 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.